FMR LLC 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX | FMR LLC | 8,363,529 3.040% | -2,533,757 (-23.25%) | Filing |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX | FMR LLC | 10,897,286 5.231% | 10,897,286 (New Position) | Filing |